Results
10
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
10 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
XTP | zł99.50 | -3.8% | -33.9% | zł225.8m | zł152.00 | PS19x | E129.2% | n/a | Tech | ||
CTX | zł51.60 | -12.5% | -42.7% | zł240.6m | zł121.13 | PS12.4x | E71.9% | n/a | Pharmaceuticals & Biotech | ||
SHO | zł40.80 | -6.2% | 21.8% | zł1.1b | zł50.75 | PE35.1x | E24.8% | 1.6% | Software | ||
VGO | zł425.00 | -4.5% | -2.5% | zł371.8m | zł574.07 | PE67.1x | E36.9% | 0% | Tech | ||
VRC New | zł116.50 | -3.7% | 76.0% | zł2.6b | zł125.17 | PE30.4x | E21.7% | 1.4% | Software | ||
CMR | zł330.00 | -0.3% | 83.8% | zł2.7b | zł267.00 | PE36.1x | E24.6% | 1.5% | Software | ||
CDR | zł158.00 | -0.3% | 38.8% | zł15.8b | zł134.72 | PE28.1x | E17.1% | 0.6% | Media | ||
GPP | zł53.80 | -0.9% | -12.5% | zł3.7b | zł67.20 | PE20.8x | E16.2% | 3.7% | Commercial Services | ||
SLV | zł52.50 | -4.7% | -12.6% | zł963.7m | zł69.23 | PE20.3x | E23.3% | n/a | Pharmaceuticals & Biotech | ||
APT | zł16.82 | -9.6% | 11.8% | zł488.6m | zł20.80 | PE11.4x | E21.0% | 3.6% | Tech |